GlaxoSmithKline gearing up for Alli launch

Share this article:

GlaxoSmithKline continues to prepare for the rollout of its new OTC diet pill Alli.

The UK drugmaker is scheduled to begin shipping Alli to US pharmacies today, with the weight loss remedy expected to officially go on sale next Monday.

Early demand from retailers has been strong from retailers, including Wal-Mart Stores, and 400,000 Alli starter kits are being shipped to fill the supply chain.

Analysts estimate the launch of Alli will be one of the biggest ever for an OTC medicine. GlaxoSmithKline is spending an estimated $150 million on marketing in the US.

Alli will retail for between $55 and $60 for a month’s supply, based on a regimen of three pills a day.

Citigroup estimates global Alli sales could hit $724 million by 2011.

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.